TREM2-independent oligodendrocyte, astrocyte, and T cell responses to tau and amyloid pathology in mouse models of Alzheimer disease

Seung-Hye Lee,Mitchell G Rezzonico,Brad A Friedman,Melanie H Huntley,William J Meilandt,Shristi Pandey,Ying-Jiun J Chen,Amy Easton,Zora Modrusan,David V Hansen,Morgan Sheng,Christopher J Bohlen,Mitchell G. Rezzonico,Brad A. Friedman,Melanie H. Huntley,William J. Meilandt,Ying-Jiun J. Chen,David V. Hansen,Christopher J. Bohlen

DOI: https://doi.org/10.1016/j.celrep.2021.110158

IF: 8.8

2021-12-01

Cell Reports

Abstract:Non-neuronal responses in neurodegenerative disease have received increasing attention as important contributors to disease pathogenesis and progression. Here we utilize single-cell RNA sequencing to broadly profile 13 cell types in three different mouse models of Alzheimer disease (AD), capturing the effects of tau-only, amyloid-only, or combined tau-amyloid pathology. We highlight microglia, oligodendrocyte, astrocyte, and T cell responses and compare them across these models. Notably, we identify two distinct transcriptional states for oligodendrocytes emerging differentially across disease models, and we determine their spatial distribution. Furthermore, we explore the impact of Trem2 deletion in the context of combined pathology. Trem2 knockout mice exhibit severely blunted microglial responses to combined tau and amyloid pathology, but responses from non-microglial cell types (oligodendrocytes, astrocytes, and T cells) are relatively unchanged. These results delineate core transcriptional states that are engaged in response to AD pathology, and how they are influenced by a key AD risk gene, Trem2.

cell biology